Get started
Author

Federica Spinnato

Observed names: F Spinnato, F. Spinnato
ORCID: 0000-0001-9689-6267
Observed ORCID: 0000-0001-9689-6267
OpenAlex ID: A5040213241
Acquired subglottic cysts in children: A rare and challenging clinical entity. A systematic review
2020 · Davide Soloperto, Federica Spinnato, et al. · International Journal of Pediatric Otorhinolaryngology · 13
New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease
2017 · Raquel N. Taddei, Federica Spinnato, et al. · International review of neurobiology · 9
P48.03 First-Line Durvalumab plus Platinum-Etoposide in ES-SCLC: Exploratory Analyses Based on Extent of Disease in CASPIAN
2021 · N. Reinmuth, M.C. Garassino, et al. · Journal of Thoracic Oncology · 7
PDF
1533P Atezolizumab (ATZ) plus carboplatin (Cb) and etoposide (eto) in patients with untreated extensive-stage small cell lung cancer (ES-SCLC): Results from the interim analysis of MAURIS trial
2022 · E. Bria, M.C. Garassino, et al. · Annals of Oncology · 3
PDF
A phase 2 study of oxaliplatin (O) -capecitabine (C) chemotherapy in metastatic breast cancer (MBC) patients pretreated with anthracyclines and taxane
2004 · N. Gebbia, F. Fulfaro, et al. · Journal of Clinical Oncology · 2
2001P Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
2023 · V. Longo, F. Vitiello, et al. · Annals of Oncology · 1
PDF
P3.18.18 Predictive Role of Respiratory Function Tests on Lung Toxicity in Stage III NSCLC Under Chemo-Radiotherapy and Durvalumab: Preludio Trial
2025 · P.M. Medusa, C.M. Della Corte, et al. · Journal of Thoracic Oncology
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL
2025 · P.M. Medusa, N. Carro, et al. · Lung Cancer
Erstlinienbehandlung mit Durvalumab plus Platin-Etoposid beim ED-SCLC: Explorative Analysen basierend auf dem Ausmaß der Erkrankung in CASPIAN
2021 · H Bischoff, N Reinmuth, et al. · Pneumologie
Detection of EGFR mutations in tissue and plasma of NSCLC Patients
2016 · M.G. Bica, C. Russo Lacerna, et al. · Annals of Oncology
PDF
Oral Chemotherapy in Elderly Patients With Advanced Non Small Cell Lung Carcinoma
2014 · Sebastiano Bordonaro, L. Vizzini, et al.
Indagine sulla qualità di vita ansia e depressione in un gruppo di pazienti affette da carcinoma mammario
2006 · C Adile, C Scibilia, et al. · Nova Science Publishers (Nova Science Publishers, Inc.)
The use of somatostatin analogues in metastatic hormone refractory and chemo resistant prostate cancer with neuroendocrine differentiation.
2005 · Giuseppe Badalamenti, Fabio Fulfaro, et al.
The Use of Gemcitabine in heavily pretreted breast cancer patients
2005 · Valerio Mr, B Benfante, et al. · Nova Science Publishers (Nova Science Publishers, Inc.)
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004
2004 · Nicolo' Gebbia, Maria Rosaria Valerio, et al.
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004
2004 · Nicolo' Gebbia, Antonio Russo, et al.
Works count: 16
Citation count: 35
H-index: 3
I10-index: 1
Year
Topic
Type